Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus vs MMF with Tacrolimus in Renal Transplant
NCT01025817Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2010
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of everolimus in kidney transplant rejection, sponsored by Novartis. Started Jan 2010; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01025817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01025817.